/
Navigation
Chronicles
Browse all articles
Explore
Semantic exploration
Research
Entity momentum
Nexus
Correlations & relationships
Story Arc
Topic evolution
Drift Map
Semantic trajectory animation
Posts
Analysis & commentary
Pulse API
Tech news intelligence API
Browse
Entities
Companies, people, products, technologies
Domains
Browse by publication source
Handles
Browse by social media handle
Detection
Concept Search
Semantic similarity search
High Impact Stories
Top coverage by position
Sentiment Analysis
Positive/negative coverage
Anomaly Detection
Unusual coverage patterns
Analysis
Rivalry Report
Compare two entities head-to-head
Semantic Pivots
Narrative discontinuities
Crisis Response
Event recovery patterns
Connected
Search: /
Command: ⌘K
Embeddings: large
TEXXR

Chronicles

The story behind the story

days · browse · Enter similar · o open

Proximie raises $38M Series B for its AI-based AR tech that enables physicians and surgeons to interact virtually during surgical and diagnostic procedures

Digital surgery company Proximie this week announced it has raised $38 million in a Series B equity financing round.

Medical Design and Outsourcing Nancy Crotti

Context & Ripple Effects

This April 2021 Series B put Proximie on the funding ladder that its later coverage confirms: within about fourteen months the company followed up with an $80M Series C that lifted total funding to $129M, suggesting investors saw the $38M round as fuel for scaling rather than survival.

The round also landed in a crowded lane. Proprio had already pulled in a $23M Series A for computational imaging aimed at surgical accuracy, Medivis later raised $20M for holographic MRI/CT rendering with its SurgicalAR tool, and Proprio's momentum continued with a $43M Series B for real-time 3D surgery visualization — making Proximie's raise part of a sustained capital build-out across surgical AR and visualization.

First-order effects

  • Proximie gains the runway to expand its AI-based platform that lets physicians and surgeons interact virtually during live surgical and diagnostic procedures, moving from pilot deployments toward broader hospital adoption.
  • Competing visualization startups like Proprio and Medivis now face a better-funded rival pushing virtual surgical collaboration into the same operating rooms they target.

Second-order effects

  • Hospital buyers evaluating surgical AR gain multiple funded vendors to choose among, which pushes differentiation toward clinical outcomes and integration rather than the technology demo itself.
  • The steady drumbeat of raises — Proprio's Series A then Series B, Medivis' Series A, Proximie's Series B then Series C — signals to other medtech investors that surgical AR is a fundable category, likely drawing more entrants and capital.

Third-order effects

  • If the funding pattern holds, surgical AR moves from novelty to standard OR infrastructure, with hospitals procuring remote-collaboration capability much like imaging equipment — and consolidation pressure building once several well-funded platforms chase the same accounts.

The trend: Venture capital is steadily building out a surgical AR and visualization stack, with successive rounds at Proximie, Proprio, and Medivis turning virtual operating-room collaboration into an institutionalized medtech category.